Business Wire - Biovail Launches Cardizem LA to Physicians; Schedules Q1 Earnings Release for April 29, 2003
Saturday, November 15th, 2008 Business Editors/Health/Medical Writers
TORONTO–(BUSINESS WIRE)–April 2, 2003
Biovail Corporation (NYSE:BVF)(TSX:BVF) announced today that it has officially launched Cardizem(R) LA in the U.S. Launch elements include physician detailing, sampling, marketing and promotional activities. Biovail, in conjunction with the Company’s co-promotion partner Reliant Pharmaceuticals LLP, has approximately 800 sales representatives that…
